兴齐眼药：预计2025年净利同比增长95.82%-121.56%

Core Viewpoint - The company Xingqi Eye Medicine (300573) has announced its earnings forecast for 2025, projecting a net profit attributable to shareholders of between 662 million to 749 million yuan, representing a year-on-year growth of 95.82% to 121.56% [4] Financial Performance - The expected net profit for 2025 is between 662 million to 749 million yuan, with a non-recurring net profit also projected in the same range, indicating a year-on-year growth of 90.48% to 115.51% [4] - As of January 22, the company's price-to-earnings ratio (TTM) is approximately 25.78 to 29.17 times, the price-to-book ratio (LF) is about 10.29 times, and the price-to-sales ratio (TTM) is around 8.02 times [4] Company Strategy - The company has maintained a focus on independent research and development, reinforcing its core competitive advantages, increasing market expansion efforts, optimizing product structure, and enhancing cost control, which has contributed to stable growth in both revenue and net profit [13]